A-Z of Patient Information Leaflets

You can also view Patient Information Leaflets by Service.

Leaflets can be translated on-demand by pressing the 'Accessibility' button at the top of this page, and then choose 'Translate this page'. Alternatively you can request leaflets in another language or format by contacting our Patient and Family Experience Team.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

  • Galcanezumab (Emgality®)

    Galcanezumab (Emgality®) is a monoclonal antibody treatment which is now available on the NHS as a possible treatment for preventing migraine in people who:

    • have four or more migraine days a month
    • have tried at least three other preventative medications which have not worked
    • have completed three months of headache diaries (including HIT-6)
    • lifestyle modifications (medication and caffeine use) have been addressed